Marc Gauthier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Marc Gauthier

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Biomed Research International|May 9, 2018

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French StudyEric Hachulla, Gwendal Le Masson, Guilhem Solé, et al.

The Journal of Allergy and Clinical Immunology|March 9, 2023

CCL5 is a potential bridge between type 1 and type 2 inflammation in asthmaMarc Gauthier, Sagar Laxman Kale, Timothy B Oriss, et al.

American Journal of Respiratory and Critical Care Medicine|November 27, 2024

Type 1 Immune Responses Related to Viral Infection Influence Corticosteroid Response in AsthmaJohn V Fahy, Nathan D Jackson, Satria P Sajuthi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Biomed Research International|May 9, 2018

Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French StudyEric Hachulla, Gwendal Le Masson, Guilhem Solé, et al.

The Journal of Allergy and Clinical Immunology|March 9, 2023

CCL5 is a potential bridge between type 1 and type 2 inflammation in asthmaMarc Gauthier, Sagar Laxman Kale, Timothy B Oriss, et al.

American Journal of Respiratory and Critical Care Medicine|November 27, 2024

Type 1 Immune Responses Related to Viral Infection Influence Corticosteroid Response in AsthmaJohn V Fahy, Nathan D Jackson, Satria P Sajuthi, et al.

Pageof 2